MARKET

CSCIF

CSCIF

Cosciens Biopharma
OTCMQB
1.840
+0.160
+9.52%
Closed 10:32 05/20 EDT
OPEN
1.840
PREV CLOSE
1.680
HIGH
1.840
LOW
1.840
VOLUME
100
TURNOVER
184
52 WEEK HIGH
4.400
52 WEEK LOW
0.791
MARKET CAP
5.86M
P/E (TTM)
-0.3062
1D
5D
1M
3M
1Y
5Y
1D
COSCIENS Biopharma Calls June 17, 2026 Special and Annual Shareholder Meeting
TipRanks · 8h ago
Weekly Report: what happened at CSCIF last week (0511-0515)?
Weekly Report · 2d ago
COSCIENS Biopharma posts sharp Q1 profit and stronger balance sheet in May 2026 filing
TipRanks · 05/12 22:45
COSCIENS Biopharma Posts Q1 Profit as German Units Exit and SEC Reporting Cutback Advances
TipRanks · 05/12 22:44
Cosciens Biopharma Q1 EPS $2.90 Up From $(1.16) YoY, Sales $1.888M Up From $1.387M YoY
Benzinga · 05/12 21:59
COSCIENS Biopharma Inc. GAAP EPS of -$0.06, revenue of $1.9M
Seeking Alpha · 05/12 21:29
Canada's COSCIENS Biopharma Q1 net income turns positive on discontinued German operations
Reuters · 05/12 21:14
COSCIENS BIOPHARMA INC. REPORTS Q1 2026 RESULTS
Reuters · 05/12 21:05
More
About CSCIF
COSCIENS Biopharma Inc. is a Canada-based life science company. The Company is developing and commercializing a diversified portfolio of products for the cosmeceutical, nutraceutical and pharmaceutical markets. The Company’s patented technologies include the Pressurized Gas eXpanded (PGX) technology, which is a technology that generates high-value yields of active ingredients from natural-based resources for use in novel cosmeceutical, nutraceutical and pharmaceutical products. The Company's two products, oat beta glucan and avenanthramides, are found in household-name cosmetic and personal care brands. These products are manufactured from the Company’s proprietary oat extraction manufacturing technology and are known for their well-documented health benefits. Its lead product, macimorelin (Macrilen; Ghryvelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD).

Webull offers COSCIENS Biopharma Inc (USA) stock information, including OTCMQB: CSCIF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSCIF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CSCIF stock methods without spending real money on the virtual paper trading platform.